Provider
P34-17 Addition of Drug to the Amitiza (lubiprostone), Linzess (linaclotide), and Trulance (plecanatide) Prior Authorization Program
Program effective Date: Jun 13, 2017
Search Results
Displaying 2671 - 2680 of 4204 results
Provider
P27-17 New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Antifungal Agents
Program effective Date: May 25, 2017
Provider
P58-17 New Drug-Related Prior Authorization with Quantity Limit Criteria: Topical Doxepin
Program effective Date: Oct 24, 2017
Provider
P59-16 Organization Determination Additions for Platinum Blue - Effective January 23, 2017
Program effective Date: Dec 08, 2016
Provider
P51-16 Addition of a Drug (Belviq XR) to the Weight Loss Agents Prior Authorization with Quantity Limit Program
Program effective Date: Oct 28, 2016
Provider
QP92-24 Process Update for Post-Acute Care Authorizations managed by eviCore Healthcare
Program effective Date: Dec 23, 2024
Provider
QP91-24 Commercial Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective February 1, 2025
Program effective Date: Dec 23, 2024
Provider
QP90-24 MHCP Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective January 1, 2025
Program effective Date: Dec 23, 2024
Provider
QP93-24 Blue Cross and Blue Shield of Minnesota Collaborating with Maven
Program effective Date: Dec 23, 2024
Provider
QP94-24 MHCP Pharmacy Benefit Exclusion for Darzalex Faspro®, Supprelin® LA and Visudyne®
Program effective Date: Dec 23, 2024